NEURO62

Session information

English Poster Session

[Pe-13] English Poster Session 13 Cerebrovascular disorder 03

Thu. May 20, 2021 11:00 AM - 11:40 AM Room 15 (ICC Kyoto 1F New Hall)

Xuejin Cao1,2, Zan Wang1,2, Yanli Liu4, Idriss Ali. Abdoulaye1,2, Xiaohui Chen2,3, Shiyao Zhang1,2, Xiaoying Guo1,2, Shanshan Wu1,2, Yijing Guo1,2,5 (1.Department of Neurology, Affiliated ZhongDa Hospital of Southeast University, China, 2.School of Medicine, Southeast University, China, 3.Department of Radiology, Affiliated ZhongDa Hospital of Southeast University, 4.Department of Rehabilitation, Affiliated ZhongDa Hospital of Southeast University, 5.Lishui People Hospital, ZhongDa Hospital Lishui Branch, Southeast University)

Masako Kinoshita1, Kazuaki Sato2, Hiroya Ohara3, Vellingiri Balachandar4, Shawn J. Green5, Masami Tanaka6,7 (1.Department of Neurology, National Hospital Organization Utano National Hospital, Japan, 2.Department of Neurology, Ijinkai Takada General Hospital, 3.Department of Neurology, Minaminara General Medical Center, 4.Department of Human Genetics and Molecular Biology, Bharathiar University, 5.Lundquist Institute at Harbor-UCLA Medical Center, Lundquist Institute for Biomedical Innovation, 6.Kyoto MS Center, Kyoto Min-Iren Chuo Hospital, 7.Department of Neurology, Kaikoukai Josai Hospital)

Kenji Sakai1, Moeko Noguchi-shinohara1,2, Tokuhei Ikeda1,3, Tsuyoshi Hamaguchi1, Kenjiro Ono1,4, Masahito Yamada1 (1.Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Japan, 2.Department of Preemptive Medicine for Dementia, Kanazawa University Graduate School of Medical Sciences, 3.Department of Neurology, Ishikawa Prefectural Central Hospital, 4.Department of Neurology, Showa University School of Medicine)

Masahiro Uemura1, Shouichiro Ando1, Hiroaki Nozaki2, Ikuko Mizuta3, Takeshi Ikeuchi4, Toshiki Mizuno3, Hidekazu Tomimoto5, Osamu Onodera1 (1.Department of Neurology, Brain Research Institute (BRI), Niigata University, Niigata, Japan, 2.Department of Medical Technology, Health Sciences Faculty of Medicine, Niigata University, Niigata, Japan, 3.Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 4.Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan, 5.Department of Neurology, Mie University Graduate School of Medicine, Kyoto, Japan)

Rie Saito1, Hiroaki Nozaki2, Kazuki Tainaka3, Masahiro Uemura2, Masahiro Suzuki4, Masaharu Tanaka5, Arika Hasegawa6, Takashi Abe7, Aki Sato8, Hideki Hashidate9, Shuichi Igarashi8, Ryoko Koike8, Osamu Onodera2, Akiyoshi Kakita1 (1.Department of Pathology, Brain Research Institute, Niigata University, Japan, 2.Department of Neurology, Brain Research Institute, Niigata University, 3.Department of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, 4.Department of Neurology, Mishima Hospital, 5.Department of Psychiatry, Mishima Hospital, 6.Department of Neurology, Nishi-Niigata Chuo National Hospital, 7.Department of Hematology, Niigata City General Hospital, 8.Department of Neurology, Niigata City General Hospital, 9.Department of Pathology, Niigata City General Hospital)